StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)

Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%

Lifevantage gross margin

Gross margin is gross profit as a percentage of revenue.

Lifevantage's gross margin for the twelve months ending Sep 30, 2026 was 76.5%. For fiscal 2026 it was 77.6%, against 80.4% the year before. The highest annual figure on record is 85.7% in fiscal 2012.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202677.6%−2.8
FY2025Jun 30, 202580.4%+1.1
FY2024Jun 30, 202479.3%−0.4
FY2023Jun 30, 202379.7%−1.9
FY2022Jun 30, 202281.5%−1.1
FY2021Jun 30, 202182.7%−1.0
FY2020Jun 30, 202083.7%+0.5
FY2019Jun 30, 201983.2%+0.3
FY2018Jun 30, 201882.9%−0.4
FY2017Jun 30, 201783.2%−0.3
FY2016Jun 30, 201683.6%−1.7
FY2015Jun 30, 201585.3%+0.8
FY2014Jun 30, 201484.5%+2.1
FY2013Jun 30, 201382.4%−3.3
FY2012Jun 30, 201285.7%+0.9
FY2011Jun 30, 201184.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202675.4%−4.2
Q4 FY2026CQ2 2026Jun 30, 202678.0%−1.9
Q3 FY2026CQ1 2026Mar 31, 202679.0%−2.0
Q2 FY2026CQ4 2025Dec 31, 202574.0%−6.5
Q1 FY2026CQ3 2025Sep 30, 202579.5%−0.4
Q4 FY2025CQ2 2025Jun 30, 202579.9%+0.4
Q3 FY2025CQ1 2025Mar 31, 202581.0%+2.1
Q2 FY2025CQ4 2024Dec 31, 202480.5%+2.0
Q1 FY2025CQ3 2024Sep 30, 202479.9%−0.3
Q4 FY2024CQ2 2024Jun 30, 202479.5%−0.1
Q3 FY2024CQ1 2024Mar 31, 202478.9%−1.3
Q2 FY2024CQ4 2023Dec 31, 202378.6%+0.5
Q1 FY2024CQ3 2023Sep 30, 202380.2%−0.6
Q4 FY2023CQ2 2023Jun 30, 202379.6%−2.1
Q3 FY2023CQ1 2023Mar 31, 202380.2%−0.4
Q2 FY2023CQ4 2022Dec 31, 202278.1%−3.4
Q1 FY2023CQ3 2022Sep 30, 202280.8%−1.5
Q4 FY2022CQ2 2022Jun 30, 202281.7%−0.5
Q3 FY2022CQ1 2022Mar 31, 202280.7%−2.2
Q2 FY2022CQ4 2021Dec 31, 202181.5%−1.3
Q1 FY2022CQ3 2021Sep 30, 202182.3%−0.6
Q4 FY2021CQ2 2021Jun 30, 202182.1%−1.9
Q3 FY2021CQ1 2021Mar 31, 202182.9%−0.9
Q2 FY2021CQ4 2020Dec 31, 202082.7%−0.6
Q1 FY2021CQ3 2020Sep 30, 202082.9%−0.8
Q4 FY2020CQ2 2020Jun 30, 202084.1%+1.4
Q3 FY2020CQ1 2020Mar 31, 202083.8%+0.3
Q2 FY2020CQ4 2019Dec 31, 201983.3%+0.1
Q1 FY2020CQ3 2019Sep 30, 201983.7%+0.2
Q4 FY2019CQ2 2019Jun 30, 201982.7%−2.3
Q3 FY2019CQ1 2019Mar 31, 201983.4%+1.1
Q2 FY2019CQ4 2018Dec 31, 201883.2%+1.6
Q1 FY2019CQ3 2018Sep 30, 201883.5%+1.2
Q4 FY2018CQ2 2018Jun 30, 201885.1%+2.6
Q3 FY2018CQ1 2018Mar 31, 201882.4%+0.6
Q2 FY2018CQ4 2017Dec 31, 201781.6%−3.1
Q1 FY2018CQ3 2017Sep 30, 201782.2%–
Q4 FY2017CQ2 2017Jun 30, 201782.4%–
Q3 FY2017CQ1 2017Mar 31, 201781.7%–
Q2 FY2017CQ4 2016Dec 31, 201684.7%–

More Lifevantage figures

See a number that looks wrong?